This is a transitional step ahead of the broader BALANCE model rollout in January 2027, which may expand coverage further
These benefits were further supported by the results of the SUMMIT trial, which investigated tirzepatide, a dual GLP-1/glucose-dependent insulinotropic polypeptide receptor agonist, in patients with HFpEF with or without T2D
Before the injection Step 1: Prepare the medication
Peptides are complex molecules, and even small structural variations can change how they behave in the body
Faraj M, Havel PJ, Phelis S, Blank D, Sniderman AD, Cianflone K
The study authors concluded that reactive hypoglycemia in dumping syndrome following bariatric surgery is caused by increased GLP-1 concentration potentiating insulin release ( Another similar study measured plasma incretin, insulin, and glucose concentration in gastrectomy patients compared to controls